These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7186080

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
    Burkin MA, Sviridov VV, Perelygina OV.
    Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
    [Abstract] [Full Text] [Related]

  • 3. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.
    Qazi O, Sesardic D, Tierney R, Söderbäck Z, Crane D, Bolgiano B, Fairweather N.
    Infect Immun; 2006 Aug; 74(8):4884-91. PubMed ID: 16861677
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.
    Raju R, Diethelm-Okita B, Okita D, Conti-Fine BM.
    J Autoimmun; 1996 Feb; 9(1):79-88. PubMed ID: 8845057
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Studies on the antigenic structure of tetanus toxin.
    Bizzini B, Raynaud M.
    Ann Immunol (Paris); 1975 Feb; 126(2):159-76. PubMed ID: 53028
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of tetanus toxoid-specific immune responses by a traditional Chinese herbal medicine.
    Underwood JR, Chivers M, Dang TT, Licciardi PV.
    Vaccine; 2009 Nov 05; 27(47):6634-41. PubMed ID: 19781825
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intranasal immunisation against tetanus with an attenuated Bordetella bronchiseptica vector expressing FrgC: improved immunogenicity using a Bvg-regulated promoter to express FrgC.
    Stevenson A, Roberts M.
    Vaccine; 2004 Oct 22; 22(31-32):4300-5. PubMed ID: 15474722
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB/c mice against lethal challenge.
    Munro P, Flatau G, Lemichez E.
    Vaccine; 2007 Dec 17; 25(52):8702-6. PubMed ID: 18035455
    [Abstract] [Full Text] [Related]

  • 16. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.
    Robinson K, Chamberlain LM, Schofield KM, Wells JM, Le Page RW.
    Nat Biotechnol; 1997 Jul 17; 15(7):653-7. PubMed ID: 9219268
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of enhancing factor (EF) prepared from spleen of mice immunized with tetanus toxoid.
    Barna-Vetró I, Varró R, Osz E.
    Ann Immunol Hung; 1979 Jul 17; 19():143-8. PubMed ID: 552221
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.